Autopsy report · NCT06416436

Dose-escalation Study of Ultra-high Dose Ablative Radiosurgery With Immunotherapy for Bulky Metastatic Cancer Patients

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Impasse during contract negotitations”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 1
Sponsor: University of Kansas Medical Center
Sponsor type: University, hospital or other
Conditions: Solid Tumor
Interventions: Atezolizumab; Stereotactic Ablative Radiotherapy (SBRT)
Participants: 0
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.